Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	25.42B +2.5%
Revenue (ttm)	5.90B -17.4%
Net Income	1.74B -18.3%
EPS	1.89 -18.5%
Shares Out	921.66M
PE Ratio	14.59
Forward PE	n/a
Dividend	1.74 (6.22%)
Ex-Dividend Date	Jun 30, 2025

Volume	5,031,789
Open	27.52
Previous Close	27.58
Day's Range	27.22 - 27.65
52-Week Range	24.12 - 29.60
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, hemostasis, gynecology, pneumology, gastroenterology, and geriatrics. The company is headquartere...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,026
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2025, SHA:600566's revenue was 6.22 billion, a decrease of -22.43% compared to the previous year's 8.02 billion. Earnings were 1.78 billion, a decrease of -29.77%.